Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 2:48 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 313–336 of 1,098 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Physiological Clear all

Conditions: Type 1 Diabetes, Type 2 Diabetes
Interventions: h-Patch; Device
Lead sponsor: Valeritas, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Malignancies, Stenosis of Vagina
Interventions: Not listed
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Acute Kidney Failure
Interventions: Furosemide; Drug
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2022
U.S. locations: 4
States / cities: San Francisco, California • Washington D.C., District of Columbia • Chicago, Illinois + 1 more

Conditions: type1diabetes, Obesity
Interventions: Hyperinsulinemic-euglycemic clamp, High Fat Mixed Meal Tolerance Test; Biological · Other
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 30 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Anemia of End Stage Renal Disease
Interventions: MDGN201 TARGTEPO; Biological
Lead sponsor: Aevi Genomic Medicine, LLC, a Cerecor company; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Hypogonadism, Erectile Dysfunction
Interventions: Testim®, Placebo Testim®, Viagra®; Drug · Other
Lead sponsor: Mohit Khera; Other
Eligibility: 18 Years and older · Male only
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2013
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Major Depression
Interventions: venlafaxine (Effexor), placebo; Drug · Other
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 65 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1996 – 1998
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Succinic Semialdehyde Dehydrogenase
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 12 Years and older
Enrollment: 7 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Stress, Physiological Stress
Interventions: Sedative Music, Stimulative Music; Behavioral
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 3
States / cities: Coral Gables, Florida

Conditions: Nuclear Cataract
Interventions: High Intraocular Pressure (IOP), Low Intraocular Pressure (IOP); Other
Lead sponsor: Matthew Rauen; Other
Eligibility: Not listed
Enrollment: 65 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: West Des Moines, Iowa

Conditions: Sleep
Interventions: sodium oxybate; Drug
Lead sponsor: St. Luke's Hospital, Chesterfield, Missouri; Other
Eligibility: 18 Years to 50 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Chesterfield, Missouri

Conditions: Mental Health and General Well-being
Interventions: Miracle of Mind meditation, Neutral audio learning task; Behavioral
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years to 40 Years
Enrollment: 354 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Erectile Dysfunction, Cardiac Disease
Interventions: ARM 1: AdMSC: adipose stem cells, ARM 2: Placebo; Biological · Other
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 40 Years and older · Male only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2022
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Cancer
Interventions: La Roche Posay Lipikar Wash Atopy-Prone Plus (AP+) Moisturizing Face and Body Wash, La Roche Posay Lipikar AP+ Triple Repair Moisturizing Cream, La Roche Posay Cicaplast balm Panthenol/Vitamin B5 (B5+); Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Intraabdominal Hypertension, Abdominal Compartment Syndrome, Acute Kidney Injury, Cardiovascular Surgery
Interventions: Accuryn Monitoring System; Device
Lead sponsor: Potrero Medical; Industry
Eligibility: 18 Years and older
Enrollment: 2,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 9
States / cities: Los Angeles, California • San Francisco, California • Washington D.C., District of Columbia + 6 more

Conditions: Ischemia, Stress, Mental
Interventions: Coronary CT Angiography, Mood Symptom Scale, Anxiety Symptom Scale, Chronic Stress Inventories, Psychosocial Function Questionnaires, General Health and quality of life questionnaires, Magnetic Resonance Imaging; Radiation · Other
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 50 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: PHYSIOLOGICAL PHENOMENA, Homeostasis, Physical Functional Performance, Cardiorespiratory Fitness, Cardiometabolic Risk Factors, Mobility Limitation
Interventions: Standardized Physiologic Resilience Challenge, Multimodal Whole-Body Physiologic Monitoring, Research-Only Whole-Body Digital Twin Analysis; Procedure · Other
Lead sponsor: Truway Health, Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 450 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2041
U.S. locations: 1
States / cities: New York, New York

Conditions: Critical Illness, Physiological Stress, Delirium, Sleep Deprivation
Interventions: Sound reduction, Sound masking; Device
Lead sponsor: Brian Gehlbach; Other
Eligibility: 18 Years to 99 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2024
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Stress
Interventions: MindBreaks - Audio-visual, MindBreaks - Auditory-only, MindBreaks - Visual-only; Behavioral
Lead sponsor: Well Living Lab, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Prostatic Neoplasm, Survivorship, Frailty, Aging, Metastatic Breast Cancer
Interventions: Dietary recommendations, Time-restricted eating; Behavioral
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 55 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Obstetric; Injury Pelvic Floor, Sexual Dysfunction, Anal Incontinence, Urinary Incontinence
Interventions: Estradiol 0.01% Vag Cream, Placebo vaginal cream; Drug
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older · Female only
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Virus Diseases, RNA Virus Infections, Respiratory Tract Diseases, Respiratory Tract Infections
Interventions: Low dose of quadrivalent VLP vaccine, Medium dose of quadrivalent VLP vaccine, High dose of quadrivalent VLP vaccine, Placebo; Biological
Lead sponsor: Medicago; Industry
Eligibility: 18 Years to 49 Years
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 2
States / cities: Hollywood, Florida • Miami, Florida

Conditions: Respiratory Distress Syndrome in Premature Infant
Interventions: High flow nasal cannula, Nasal CPAP; Procedure
Lead sponsor: Sharp HealthCare; Other
Eligibility: 23 Weeks to 28 Weeks
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: San Diego, California

Conditions: To Assess the Safety and Tolerabiltiy of an Amino Acid Composition in Subjects With Sickle Cell Disease, Anemia, Sickle Cell, Sickle Cell Anemia, Sickle Cell Disorders, Sickle Cell Disease
Interventions: AXA4010; Dietary Supplement
Lead sponsor: Axcella Health, Inc; Industry
Eligibility: 12 Years and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 4
States / cities: Hollywood, Florida • Miami, Florida • Atlanta, Georgia + 1 more

Search by objective public record fields.

Patient Preference of h-Patch vs. Pen or Needle/Syringe as Insulin Administration Device

Longitudinal Evaluation Study of Vaginal Stenosis With and Without Pelvic Radiation Therapy

The Effect of Loop Diuretics on Severity and Outcome of Acute Kidney Injury

Physiologic Markers of Cardiometabolic Risk in People With Type 1 Diabetes

TARGTEPO Treatment for Anemia in PD US Trial

Testosterone for Penile Rehabilitation After Radical Prostatectomy

Physiologic Monitoring of Antidepressant Response

Taurine Therapy for SSADH Deficiency

The Effect of Music Listening on Nursing Students

Less Discomfort and Less Pharmacology. Cataract Surgery at Physiologic Intraocular Pressure (IOP)

Enhancing Slow Wave Sleep With Sodium Oxybate

Effect of a Brief Daily Digital Meditation on Well-Being in US Young Adults (BEGIN II)

Stem Cells for the Improvement of Erectile and Cardiac Function in Aging Men

Skin Changes From the Use of Moisturizers in Participants With Cancer Experiencing Dermatological Adverse Events

Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry

Neurocardiac Interactions Evaluated by Anatomic and Physiologic MRI Assessment

Truway Whole-Body Digital Twin and Physiologic Resilience Study (TRU-OMNIBODY)

Trial to Evaluate the Effects of Sound Modulation on Critically Ill Patients

Acute Stress Recovery

Towards Understanding Between ADT Treatment, Circadian Rhythm, and Physiological Responsiveness

Topical Vaginal Estrogen for Postpartum Obstetric Anal Sphincter Injury Recovery

Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal Virus-Like-Particle Quadrivalent Influenza Vaccine in Adults

Physiological Changes With High-Flow Nasal Cannula

To Assess Safety, Tolerability and Physiological Effects on Structure and Function of AXA4010 in Subjects With Sickle Cell Disease